|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| C07D 471/16 |
| (11) | Number of the document | 2134710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08742074.1 |
| Date of filing the European patent application | 2008-03-12 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/003340 |
| Date | 2008-03-12 |
| (87) | Number | WO 2008/112280 |
| Date | 2008-09-18 |
| (30) | Number | Date | Country code |
| 906473 P | 2007-03-12 | US |
| (72) |
TOMESCH, John, Charles, US
LI, Peng, US
YAO, Wei, US
ZHANG, Qiang, US
BEARD, James, David, US
THOMPSON, Andrew, S., US
CHENG, Hua, US
|
| (73) |
Intra-Cellular Therapies, Inc.,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
| (54) | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS |
| SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS |